

31 January 2022
National Australia Bank (NAB): 1Q22 result preview
We discuss our 1Q22 result preview, and maintain our price target of $31.00.

17 January 2022
Commonwealth Bank (CBA): 1H22 result preview
CBA’s result will come out on Wednesday 9 February 2022 and we have collated our forecasts.

10 January 2022
Australian Pharmaceutical Industries (API): WOW Gets Cold Feet
Following completion of due diligence the WOW Board has decided to withdraw its cash bid for API.

6 January 2022
End of Quarter Review – December 2021
This calendar year has proved to be similar to 2020 in many aspects with the global financial and economic landscapes being continually dominated by the COVID-19 pandemic and its associated challenges.